Mutamycin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2017
012319752017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • RINIE J.M. VAN GILS-GIELEN
  • 2017
Objectives. In this article we describe the long-term follow-up of patients with carcinoma in situ (CIS) of the urinary bladder… (More)
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
2005
2005
BACKGROUND Small bowel adenocarcinoma is a rare gastrointestinal malignancy that is treated primarily with surgery. Even with… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2003
Review
2003
Anal cancer accounts for 1.5% of digestive system malignancies in the United States. In the past 30 years, substantial progress… (More)
Is this relevant?
2002
2002
Irinotecan and mitomycin (Mutamycin) possess significant single-agent activity against several tumor types, and mitomycin… (More)
Is this relevant?
2001
2001
The paper reports the data on treatment of 57 patients with disseminated gastric and colorectal carcinoma using a combination of… (More)
Is this relevant?
Review
2001
Review
2001
In a recent issue of ONCOLOGY (15:85-88, 2001), Drs. Edgar C. Baselli and Richard E. Greenberg presented a brief overview of… (More)
Is this relevant?
1999
1999
A trial was designed to examine the combination of UFT and mitomycin (Mutamycin) plus tamoxifen (Nolvadex) as postoperative… (More)
Is this relevant?
Review
1998
Review
1998
Sphincter-preserving treatment with combined radiation and chemotherapy has replaced abdominoperineal resection as the standard… (More)
Is this relevant?
1997
1997
This nonblinded, multicenter, randomized phase III study compares the median time to progression (primary endpoint), response… (More)
Is this relevant?
1978
1978
Pulmonary disease has been associated with several chemotherapeutic agents but has not been reported in patients receiving the… (More)
Is this relevant?